Texas invests $50M in psychedelic drug research to treat addiction
Medical Xpress
JUNE 16, 2025
The goal is to support clinical trials and bring in another $50 million in private investment to help ibogaine win approval from the U.S. Other states like Oregon and Colorado have already launched legal clinics using psilocybin, the compound found in mushrooms, The Times reported. Food and Drug Administration (FDA).
52 
Let's personalize your content